{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T01:05:00Z","timestamp":1776819900595,"version":"3.51.2"},"reference-count":36,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2005,2,1]],"date-time":"2005-02-01T00:00:00Z","timestamp":1107216000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2005,2,1]],"date-time":"2005-02-01T00:00:00Z","timestamp":1107216000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ard.eular.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of the Rheumatic Diseases"],"published-print":{"date-parts":[[2005,2]]},"DOI":"10.1136\/ard.2004.024026","type":"journal-article","created":{"date-parts":[[2004,6,8]],"date-time":"2004-06-08T01:09:06Z","timestamp":1086656946000},"page":"262-266","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":191,"title":["Tumour necrosis factor \u03b1 blocking agents in refractory adult Still's disease: an observational study of 20 cases"],"prefix":"10.1016","volume":"64","author":[{"given":"B","family":"Fautrel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J","family":"Sibilia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"X","family":"Mariette","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B","family":"Combe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1136\/ard.2004.024026_bib1","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1136\/ard.30.2.121","article-title":"Still's disease in the adult","volume":"30","author":"Bywaters","year":"1971","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2004.024026_bib2","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1136\/ard.54.7.587","article-title":"Epidemiology of adult Still's disease: estimate of the incidence by a retrospective study in west France","volume":"54","author":"Magadur-Joly","year":"1995","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2004.024026_bib3","doi-asserted-by":"crossref","first-page":"221","DOI":"10.2188\/jea.7.221","article-title":"Estimated prevalence and incidence of adult Still's disease: findings by a nationwide epidemiological survey in Japan","volume":"7","author":"Wakai","year":"1997","journal-title":"J Epidemiol"},{"key":"10.1136\/ard.2004.024026_bib4","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/0049-0172(87)90015-1","article-title":"Adult onset Still's disease: experience in 23 patients and literature review with emphasis on organ failure","volume":"17","author":"Reginato","year":"1987","journal-title":"Semin Arthritis Rheum"},{"key":"10.1136\/ard.2004.024026_bib5","first-page":"1058","article-title":"Adult Still's disease: a multicenter survey of Japanese patients","volume":"17","author":"Ohta","year":"1990","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.2004.024026_bib6","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1097\/00005792-199103000-00004","article-title":"Adult Still's disease: manifestations, disease course, and outcome in 62 patients","volume":"70","author":"Pouchot","year":"1991","journal-title":"Medicine (Baltimore)"},{"key":"10.1136\/ard.2004.024026_bib7","first-page":"748","article-title":"Adult Still's disease: part I. Manifestations and complications in sixty-five cases in France","volume":"62","author":"Masson","year":"1995","journal-title":"Rev Rhum Engl Ed"},{"key":"10.1136\/ard.2004.024026_bib8","first-page":"758","article-title":"Adult Still's disease. Part II. Management, outcome, and prognostic factors","volume":"62","author":"Masson","year":"1995","journal-title":"Rev Rhum Engl Ed"},{"key":"10.1136\/ard.2004.024026_bib9","first-page":"1139","article-title":"Adult Still's disease: review of 228 cases from the literature","volume":"14","author":"Ohta","year":"1987","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.2004.024026_bib10","first-page":"1055","article-title":"Adult-onset Still's disease; clinical and laboratory features, treatment and progress of 45 cases","volume":"61","author":"Wouters","year":"1986","journal-title":"Q J Med"},{"key":"10.1136\/ard.2004.024026_bib11","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1002\/art.1780300209","article-title":"Adult-onset Still's disease. Clinical course and outcome","volume":"30","author":"Cush","year":"1987","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2004.024026_bib12","first-page":"1088","article-title":"Treatment of fulminant adult Still's disease with intravenous pulse methylprednisolone therapy","volume":"18","author":"Khraishi","year":"1991","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.2004.024026_bib13","first-page":"1487","article-title":"Intravenous methylprednisolone pulse therapy in Still's disease","volume":"19","author":"Bisagni-Faure","year":"1992","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.2004.024026_bib14","first-page":"1582","article-title":"Cyclosporin A in the treatment of adult onset Still's disease","volume":"24","author":"Marchesoni","year":"1997","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.2004.024026_bib15","first-page":"1391","article-title":"Cyclosporin A in the treatment of adult Still's disease","volume":"22","author":"Shojania","year":"1995","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.2004.024026_bib16","first-page":"918","article-title":"Fever in adult onset Still's disease. Response to methotrexate","volume":"18","author":"Kraus","year":"1991","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.2004.024026_bib17","first-page":"431","article-title":"Low dose methotrexate treatment in adult Still's disease","volume":"19","author":"Aydintug","year":"1992","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.2004.024026_bib18","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1136\/ard.56.2.144","article-title":"Methotrexate treatment in patients with adult onset Still's disease\u2014retrospective study of 13 Japanese cases","volume":"56","author":"Fujii","year":"1997","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2004.024026_bib19","first-page":"373","article-title":"Corticosteroid sparing effect of low dose methotrexate treatment in adult Still's disease","volume":"26","author":"Fautrel","year":"1999","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.2004.024026_bib20","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/0248-8663(96)80703-X","article-title":"Treatment of Still disease in adults with intravenous immunoglobulins","volume":"16","author":"Permal","year":"1995","journal-title":"Rev Med Interne"},{"key":"10.1136\/ard.2004.024026_bib21","first-page":"295","article-title":"Intravenous immunoglobulin in adult Still's disease refractory to non-steroidal anti-inflammatory drugs","volume":"16","author":"Vignes","year":"1998","journal-title":"Clin Exp Rheumatol"},{"key":"10.1136\/ard.2004.024026_bib22","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1136\/ard.59.5.347","article-title":"Percentage of glycosylated serum ferritin remains low throughout the course of adult onset Still's disease","volume":"59","author":"Vignes","year":"2000","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2004.024026_bib23","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1136\/ard.62.suppl_2.ii2","article-title":"Updated consensus statement on biological agents for the treatment of rheumatoid arthritis and other immune mediated inflammatory diseases","volume":"62","author":"Furst","year":"2003","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2004.024026_bib24","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD003785","article-title":"Infliximab for the treatment of rheumatoid arthritis","author":"Blumenauer","year":"2002","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1136\/ard.2004.024026_bib25","first-page":"329","article-title":"Infliximab in the treatment of adult Still's disease refractory to conventional therapy","volume":"19","author":"Cavagna","year":"2001","journal-title":"Clin Exp Rheumatol"},{"key":"10.1136\/ard.2004.024026_bib26","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1136\/ard.60.90003.iii55","article-title":"Successful treatment of a small cohort of patients with adult onset of Still's disease with infliximab: first experiences","volume":"60","author":"Kraetsch","year":"2001","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2004.024026_bib27","first-page":"S229","article-title":"Etanercept in recalcitrant adult onset Still's disease","volume":"43","author":"Tamesis","year":"2000","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2004.024026_bib28","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1002\/art.10231","article-title":"Etanercept in the treatment of adult patients with Still's disease","volume":"46","author":"Husni","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2004.024026_bib29","first-page":"424","article-title":"Preliminary criteria for classification of adult Still's disease","volume":"19","author":"Yamaguchi","year":"1992","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.2004.024026_bib30","first-page":"S325","article-title":"Do patients with rheumatoid arthritis demonstrate an improvement on etanercept following an inadequate response to infliximab","volume":"48","author":"Buch","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2004.024026_bib31","first-page":"S152","article-title":"Side effects of anti-TNF therapy: current knowledge","volume":"20","author":"Antoni","year":"2002","journal-title":"Clin Exp Rheumatol"},{"key":"10.1136\/ard.2004.024026_bib32","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1097\/00002281-200205000-00002","article-title":"Tumor necrosis factor-alpha antagonists for the treatment of rheumatic diseases","volume":"14","author":"Criscione","year":"2002","journal-title":"Curr Opin Rheumatol"},{"key":"10.1136\/ard.2004.024026_bib33","doi-asserted-by":"crossref","first-page":"173","DOI":"10.2165\/00002018-200225030-00004","article-title":"Safety and efficacy of disease-modifying anti-rheumatic agents: focus on the benefits and risks of etanercept","volume":"25","author":"Fleischmann","year":"2002","journal-title":"Drug Saf"},{"key":"10.1136\/ard.2004.024026_bib34","first-page":"985","article-title":"Retrobulbar optic neuritis associated with infliximab","volume":"120","author":"Foroozan","year":"2002","journal-title":"Arch Ophthalmol"},{"key":"10.1136\/ard.2004.024026_bib35","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1007\/s10067-002-0654-5","article-title":"Anti-TNF-alpha-induced systemic lupus syndrome","volume":"22","author":"Debandt","year":"2003","journal-title":"Clin Rheumatol"},{"key":"10.1136\/ard.2004.024026_bib36","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/S0140-6736(02)07714-0","article-title":"Drug-induced systemic lupus erythematosus associated with etanercept therapy","volume":"359","author":"Shakoor","year":"2002","journal-title":"Lancet"}],"container-title":["Annals of the Rheumatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724431373?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724431373?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ard.2004.024026","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,20]],"date-time":"2025-01-20T07:55:38Z","timestamp":1737359738000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003496724431373"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,2]]},"references-count":36,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2005,2]]}},"alternative-id":["S0003496724431373"],"URL":"https:\/\/doi.org\/10.1136\/ard.2004.024026","relation":{},"ISSN":["0003-4967"],"issn-type":[{"value":"0003-4967","type":"print"}],"subject":[],"published":{"date-parts":[[2005,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tumour necrosis factor \u03b1 blocking agents in refractory adult Still's disease: an observational study of 20 cases","name":"articletitle","label":"Article Title"},{"value":"Annals of the Rheumatic Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/ard.2004.024026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2005 Copyright 2005 by Annals of the Rheumatic Diseases, Published by Elsevier Inc. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}